The metabolic testing market size has grown strongly in recent years. It will grow from $0.64 billion in 2025 to $0.69 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rising prevalence of obesity, growing use of indirect calorimetry, increased adoption of cpets in hospitals, expanding diagnostic applications, rising awareness of metabolic disorders.
The metabolic testing market size is expected to see strong growth in the next few years. It will grow to $0.91 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in personalized wellness programs, increasing sports performance analytics, rising demand for remote health monitoring, expansion of wearable metabolic sensors, increasing integration of ai-based diagnostic tools. Major trends in the forecast period include adoption of personalized metabolic health programs, AI-based metabolic rate assessment and prediction, cloud-enabled data monitoring for metabolic testing, automation of metabolic testing equipment, real-time iot-based body analytics.
The rising prevalence of chronic diseases is anticipated to drive growth in the metabolic testing market in the coming years. Chronic diseases are long-term conditions that generally persist for a year or more, requiring continuous medical care or limiting daily activities. Factors contributing to the increasing prevalence of chronic diseases include unhealthy lifestyles, poor dietary habits, and an aging population. Metabolic testing is essential in managing these conditions as it provides critical insights into an individual’s metabolic health, enabling early detection of disorders such as diabetes, cardiovascular diseases, and metabolic syndrome. This information helps tailor treatment plans and enhance overall disease management. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that chronic diseases account for 41 million deaths globally each year, representing 74% of all fatalities. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Consequently, the increasing prevalence of chronic diseases is expected to fuel demand in the metabolic testing market.
Key players in the metabolic testing market are concentrating on developing advanced testing equipment, such as metabolic analyzers, to enable real-time metabolic assessment and improve research precision. A metabolic analyzer is a medical device that measures an individual’s metabolic rate and evaluates various metabolic functions. It provides insights into how efficiently the body uses oxygen and converts food into energy, including calorie expenditure, fuel utilization (carbohydrates vs. fats), and respiratory efficiency. For instance, in September 2024, PHC Corporation, a Japan-based healthcare solutions provider, launched LiCellMo, a live cell metabolic analyzer for real-time monitoring of cellular metabolism in cell and gene therapy research. The LiCellMo analyzer offers continuous, non-invasive observation of glucose and lactate concentrations in cell cultures, giving researchers a comprehensive understanding of cellular metabolism without interrupting experiments. This enables visualization of metabolic changes in cell cultures, providing a more complete picture of cellular activity.
In September 2024, Oura, a Finland-based health technology company, acquired Veri. Through this acquisition, Oura aims to enhance its health-tracking offerings by incorporating metabolic health insights, including meal timing and blood sugar monitoring, into the Oura app, offering users a more comprehensive view of their overall health. Veri is a Finland-based developer of a blood sugar monitoring system that utilizes metabolic testing.
Major companies operating in the metabolic testing market are Becton Dickinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings LabCorp, Quest Diagnostics Incorporated, Agilent Technologies Inc., Vyaire Medical Inc., Microlife Medical Home Solutions Inc., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc, Cortex Biophysik GmbH, KORR Medical Technologies Inc., iWorx Systems Inc., General Electric Company GE Healthcare, Hologic Inc, Koninklijke Philips NV, Parvo Medics Inc, InBody Co Ltd, Schiller AG, Noraxon USA Inc, Seca GmbH Co KG.
North America was the dominant region in the metabolic testing market in 2025. Asia-Pacific is expected to be the exponential growth region in the forecast period. The regions covered in the metabolic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metabolic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on medical devices, cardiac testing systems, and metabolic diagnostic equipment have increased import costs and slowed the availability of advanced testing systems in regions dependent on foreign manufacturing. Hospitals and sports centers face higher procurement costs, especially in Asia and South America. However, tariffs are driving local production of metabolic carts and diagnostic sensors, promoting regional manufacturing expansion and reducing long-term reliance on imported equipment.
The metabolic testing market research report is one of a series of new reports that provides metabolic testing market statistics, including metabolic testing industry global market size, regional shares, competitors with a metabolic testing market share, detailed metabolic testing market segments, market trends and opportunities, and any further data you may need to thrive in the metabolic testing industry. This metabolic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Metabolic testing involves a series of medical examinations designed to measure the body's metabolic rate, including how effectively it converts food into energy, and to assess various metabolic functions. These tests examine different aspects and help identify a person's risk for obesity, diabetes, and cardiovascular conditions.
The primary forms of metabolic testing include body composition analyzers, cardiopulmonary exercise testing (CPET) systems, electrocardiogram systems (ECG), metabolic carts, and other related equipment. Body composition analyzers are devices that determine the proportion of fat, muscle, and bone in the body to evaluate overall health and fitness. They are utilized through various technological approaches, such as VO₂ max analysis, RMR analysis, and body composition analysis. The associated drug categories cover critical care, lifestyle-related diseases, and other applications, and these tests are employed by a range of end users, including hospitals and clinics, sports training centers, and other institutions.
The metabolic testing market consists of revenues earned by entities through services such as measuring resting metabolic rate (RMR), analyzing body composition, assessing caloric needs, weight management, and fitness optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The metabolic testing market also includes sales of metabolic analyzers, calorimeters, indirect calorimetry systems, and wearable metabolic tracking devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The metabolic testing market size is expected to see strong growth in the next few years. It will grow to $0.91 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in personalized wellness programs, increasing sports performance analytics, rising demand for remote health monitoring, expansion of wearable metabolic sensors, increasing integration of ai-based diagnostic tools. Major trends in the forecast period include adoption of personalized metabolic health programs, AI-based metabolic rate assessment and prediction, cloud-enabled data monitoring for metabolic testing, automation of metabolic testing equipment, real-time iot-based body analytics.
The rising prevalence of chronic diseases is anticipated to drive growth in the metabolic testing market in the coming years. Chronic diseases are long-term conditions that generally persist for a year or more, requiring continuous medical care or limiting daily activities. Factors contributing to the increasing prevalence of chronic diseases include unhealthy lifestyles, poor dietary habits, and an aging population. Metabolic testing is essential in managing these conditions as it provides critical insights into an individual’s metabolic health, enabling early detection of disorders such as diabetes, cardiovascular diseases, and metabolic syndrome. This information helps tailor treatment plans and enhance overall disease management. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that chronic diseases account for 41 million deaths globally each year, representing 74% of all fatalities. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Consequently, the increasing prevalence of chronic diseases is expected to fuel demand in the metabolic testing market.
Key players in the metabolic testing market are concentrating on developing advanced testing equipment, such as metabolic analyzers, to enable real-time metabolic assessment and improve research precision. A metabolic analyzer is a medical device that measures an individual’s metabolic rate and evaluates various metabolic functions. It provides insights into how efficiently the body uses oxygen and converts food into energy, including calorie expenditure, fuel utilization (carbohydrates vs. fats), and respiratory efficiency. For instance, in September 2024, PHC Corporation, a Japan-based healthcare solutions provider, launched LiCellMo, a live cell metabolic analyzer for real-time monitoring of cellular metabolism in cell and gene therapy research. The LiCellMo analyzer offers continuous, non-invasive observation of glucose and lactate concentrations in cell cultures, giving researchers a comprehensive understanding of cellular metabolism without interrupting experiments. This enables visualization of metabolic changes in cell cultures, providing a more complete picture of cellular activity.
In September 2024, Oura, a Finland-based health technology company, acquired Veri. Through this acquisition, Oura aims to enhance its health-tracking offerings by incorporating metabolic health insights, including meal timing and blood sugar monitoring, into the Oura app, offering users a more comprehensive view of their overall health. Veri is a Finland-based developer of a blood sugar monitoring system that utilizes metabolic testing.
Major companies operating in the metabolic testing market are Becton Dickinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings LabCorp, Quest Diagnostics Incorporated, Agilent Technologies Inc., Vyaire Medical Inc., Microlife Medical Home Solutions Inc., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc, Cortex Biophysik GmbH, KORR Medical Technologies Inc., iWorx Systems Inc., General Electric Company GE Healthcare, Hologic Inc, Koninklijke Philips NV, Parvo Medics Inc, InBody Co Ltd, Schiller AG, Noraxon USA Inc, Seca GmbH Co KG.
North America was the dominant region in the metabolic testing market in 2025. Asia-Pacific is expected to be the exponential growth region in the forecast period. The regions covered in the metabolic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metabolic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs on medical devices, cardiac testing systems, and metabolic diagnostic equipment have increased import costs and slowed the availability of advanced testing systems in regions dependent on foreign manufacturing. Hospitals and sports centers face higher procurement costs, especially in Asia and South America. However, tariffs are driving local production of metabolic carts and diagnostic sensors, promoting regional manufacturing expansion and reducing long-term reliance on imported equipment.
The metabolic testing market research report is one of a series of new reports that provides metabolic testing market statistics, including metabolic testing industry global market size, regional shares, competitors with a metabolic testing market share, detailed metabolic testing market segments, market trends and opportunities, and any further data you may need to thrive in the metabolic testing industry. This metabolic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Metabolic testing involves a series of medical examinations designed to measure the body's metabolic rate, including how effectively it converts food into energy, and to assess various metabolic functions. These tests examine different aspects and help identify a person's risk for obesity, diabetes, and cardiovascular conditions.
The primary forms of metabolic testing include body composition analyzers, cardiopulmonary exercise testing (CPET) systems, electrocardiogram systems (ECG), metabolic carts, and other related equipment. Body composition analyzers are devices that determine the proportion of fat, muscle, and bone in the body to evaluate overall health and fitness. They are utilized through various technological approaches, such as VO₂ max analysis, RMR analysis, and body composition analysis. The associated drug categories cover critical care, lifestyle-related diseases, and other applications, and these tests are employed by a range of end users, including hospitals and clinics, sports training centers, and other institutions.
The metabolic testing market consists of revenues earned by entities through services such as measuring resting metabolic rate (RMR), analyzing body composition, assessing caloric needs, weight management, and fitness optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The metabolic testing market also includes sales of metabolic analyzers, calorimeters, indirect calorimetry systems, and wearable metabolic tracking devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Metabolic Testing Market Characteristics
3. Metabolic Testing Market Supply Chain Analysis
4. Global Metabolic Testing Market Trends and Strategies
5. Metabolic Testing Market Analysis of End Use Industries
7. Global Metabolic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Metabolic Testing Total Addressable Market (TAM) Analysis for the Market
9. Metabolic Testing Market Segmentation
10. Metabolic Testing Market Regional and Country Analysis
11. Asia-Pacific Metabolic Testing Market
12. China Metabolic Testing Market
13. India Metabolic Testing Market
14. Japan Metabolic Testing Market
15. Australia Metabolic Testing Market
16. Indonesia Metabolic Testing Market
17. South Korea Metabolic Testing Market
18. Taiwan Metabolic Testing Market
19. South East Asia Metabolic Testing Market
20. Western Europe Metabolic Testing Market
21. UK Metabolic Testing Market
22. Germany Metabolic Testing Market
23. France Metabolic Testing Market
24. Italy Metabolic Testing Market
25. Spain Metabolic Testing Market
26. Eastern Europe Metabolic Testing Market
27. Russia Metabolic Testing Market
28. North America Metabolic Testing Market
29. USA Metabolic Testing Market
30. Canada Metabolic Testing Market
31. South America Metabolic Testing Market
32. Brazil Metabolic Testing Market
33. Middle East Metabolic Testing Market
34. Africa Metabolic Testing Market
36. Metabolic Testing Market Competitive Landscape and Company Profiles
37. Metabolic Testing Market Other Major and Innovative Companies
40. Metabolic Testing Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Metabolic Testing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses metabolic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for metabolic testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metabolic testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Equipment Type: Body Composition Analyzers; Cardiopulmonary Exercise Testing (CPET) Systems; Electrocardiogram Systems (ECG) Systems; Metabolic Carts; Other Equipment Types2) By Technology: VO₂ Max Analysis; RMR Analysis; Body Composition Analysis
3) By Application: Critical Care; Lifestyle Diseases; Other Applications
4) By End User: Hospitals And Clinics; Sports Training Centers; Other End Users
Subsegments:
1) By Body Composition Analyzers: Dual-Energy X-ray Absorptiometry (DXA); Bioelectrical Impedance Analysis (BIA); Air Displacement Plethysmography (ADP)2) By Cardiopulmonary Exercise Testing (CPET) Systems: Treadmill Or Cycle Ergometer-based CPET; Oxygen Consumption Measurement Systems; Gas Exchange Measurement Systems
3) By Electrocardiogram (ECG) Systems: Resting ECG Systems; Stress ECG Systems; Holter Monitors
4) By Metabolic Carts: Indirect Calorimetry Metabolic Carts; Open-Circuit Spirometry Metabolic Carts
5) By Other Equipment Types: Continuous Glucose Monitoring Systems; Lactate Testing Devices; Blood Pressure Monitoring Devices
Companies Mentioned: Becton Dickinson and Company; Lumen Technologies Inc.; Laboratory Corporation of America Holdings LabCorp; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Vyaire Medical Inc.; Microlife Medical Home Solutions Inc.; MGC Diagnostics Corporation; Geratherm Medical AG; Actofit Wearables; COSMED Srl; Levels Health Inc; Cortex Biophysik GmbH; KORR Medical Technologies Inc.; iWorx Systems Inc.; General Electric Company GE Healthcare; Hologic Inc; Koninklijke Philips NV; Parvo Medics Inc; InBody Co Ltd; Schiller AG; Noraxon USA Inc; Seca GmbH Co KG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Metabolic Testing market report include:- Becton Dickinson and Company
- Lumen Technologies Inc.
- Laboratory Corporation of America Holdings LabCorp
- Quest Diagnostics Incorporated
- Agilent Technologies Inc.
- Vyaire Medical Inc.
- Microlife Medical Home Solutions Inc.
- MGC Diagnostics Corporation
- Geratherm Medical AG
- Actofit Wearables
- COSMED Srl
- Levels Health Inc
- Cortex Biophysik GmbH
- KORR Medical Technologies Inc.
- iWorx Systems Inc.
- General Electric Company GE Healthcare
- Hologic Inc
- Koninklijke Philips NV
- Parvo Medics Inc
- InBody Co Ltd
- Schiller AG
- Noraxon USA Inc
- Seca GmbH Co KG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.69 Billion |
| Forecasted Market Value ( USD | $ 0.91 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
